Gene · 4052
Papers1,352
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,352
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis. | J Biol Chem | 2026 | 42815638 | PubTator, text mining | PubMed |
| Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance. | Cancer Heterog Plast | 2026 | 42770147 | PubTator, text mining | PubMed |
| Composition and Function of Decellularized Human Lung Extracellular Matrix from Congenital Pulmonary Airway Malformation. | J Clin Med | 2026 | 42739747 | PubTator, text mining | PubMed |
| Immune Cell-Specific Regulatory Gene Prioritization in Low Back Pain Using Single-Cell eQTL-Informed Mendelian Randomization and Colocalization. | J Pain Res | 2026 | 42677292 | PubTator, text mining | PubMed |
| Loss of MGAT3 Amplifies TGF-β Signaling to Promote Bronchiolitis Obliterans Progression. | Clin Lab | 2026 | 42570673 | PubTator, text mining | PubMed |
| Structural basis for the contribution of latent TGFβ binding protein to TGFβ latency and activation. | Nat Commun | 2026 | 42557249 | PubTator, text mining | PubMed |
| Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis. | Curr Pharm Des | 2026 | 42381324 | PubTator, text mining | PubMed |
| MCCC2 stabilizes LTBP1 via suppressing SMURF1-dependent ubiquitination to drive bone metastasis in prostate cancer. | Oncogene | 2026 | 42251191 | PubTator, text mining | PubMed |
| Screening and Validation of LTBP1 as a Key Target of Oxymatrine in Inhibiting Cardiac Fibroblast Differentiation Under High Glucose Conditions: In Vitro and Bioinformatic Studies. | Int J Mol Sci | 2026 | 42074126 | PubTator, text mining | PubMed |
| Cellular Senescence of Patient-derived Fibroblasts Reveals the Mid-old Stage as a Critical Window for Transcriptomic Signatures Linked to Alzheimer's Disease Biomarkers and Classification. | Clin Psychopharmacol Neurosci | 2026 | 42036745 | PubTator, text mining | PubMed |
| Mechanistic studies of molecular networks associated with pulmonary hypertension explored by combined transcriptome analysis of Project-methylation. | Clin Epigenetics | 2026 | 41965721 | PubTator, text mining | PubMed |
| Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts. | Clin Cancer Res | 2026 | 41954643 | PubTator, text mining | PubMed |
| TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size. | Nat Immunol | 2026 | 41862649 | PubTator, text mining | PubMed |
| Suppression of LTBP1 enhances the sensitivity of bladder cancer to cisplatin. | Sci Rep | 2026 | 41820429 | PubTator, text mining | PubMed |
Latent transforming growth factor beta binding protein 1 (LTBP1): roles as a multifunctional extracellular matrix regulator in human disease - from molecular mechanisms to clinical translation prospects. | Folia Histochem Cytobiol | 2026 | 41811083 | PubTator, text mining | PubMed |
| NOTCH3 CADASIL Variant Receptor Aggregation Requires NOTCH3 Wild-Type Receptors: Identification of Highly Selective Inhibitors That Block the Process. | FASEB J | 2026 | 41806331 | PubTator, text mining | PubMed |
| Fibronectin 1 (FN1)-rearranged Mesenchymal Neoplasms: An Updated Review. | Cancer Genomics Proteomics | 2026 | 41771581 | PubTator, text mining | PubMed |
| Emerging Targets and Treatments for Doxorubicin-Induced Cardiac Inflammation. | J Inflamm Res | 2026 | 41737243 | PubTator, text mining | PubMed |
| Acellular Adipose Tissue promotes anti-fibrotic remodeling in Phase II Study. | medRxiv | 2026 | 41728292 | PubTator, text mining | PubMed |
| 3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion. | bioRxiv | 2026 | 41726908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4052/papers